Amebiasis
ICD-10 B56 is a billable code used to indicate a diagnosis of amebiasis.
Amebiasis is an intestinal infection caused by the protozoan parasite Entamoeba histolytica. It primarily affects the gastrointestinal tract, leading to symptoms such as diarrhea, abdominal pain, and dysentery. The infection is prevalent in tropical and subtropical regions, particularly in areas with poor sanitation and hygiene practices. Transmission occurs through the fecal-oral route, often via contaminated food or water. In severe cases, amebiasis can lead to complications such as colonic perforation or liver abscesses. Diagnosis is typically made through stool examination, serological tests, or imaging studies in cases of extraintestinal involvement. Treatment usually involves the use of anti-amoebic medications such as metronidazole or tinidazole, followed by a luminal agent like iodoquinol or paromomycin to eliminate cysts from the intestinal lumen. Public health measures focusing on sanitation and hygiene are crucial in preventing the spread of this disease.
Detailed patient history, travel history, and symptomatology.
Patients presenting with diarrhea after travel to endemic areas.
Ensure documentation reflects the severity and type of amebiasis.
Endoscopic findings, biopsy results, and treatment plans.
Patients with chronic diarrhea and abdominal pain.
Document any complications such as abscess formation.
Used to confirm bacterial infections when amebiasis is suspected.
Document the reason for the culture and any relevant symptoms.
Infectious disease specialists should ensure comprehensive documentation.
Amebiasis is primarily caused by the protozoan parasite Entamoeba histolytica, which is transmitted through contaminated food and water.
